NEWHOUSE, UK (31 January 2019): BioAscent Discovery Limited’s unique on-demand compound library, Compound Cloud, has been used by the ALBORADA Drug Discovery Institut...

Scientists at deCODE Genetics showed that mutations are more likely to happen near genetic recombination sites.[/capti...

  The U.K. wants the international community to come up with a coordinated system for incentivizing the development of antimicrobials. Government officials fl...

In the largest genetic study of osteoarthritis, an international team of scientists including researchers from the University of Sheffield, have uncovered 52 new gene...

Nearly two decades after a class of once-promising cancer drugs called MMP inhibitors mysteriously failed in clinical trials, scientists think they may have an explan...

CAMBRIDGE and BOSTON, Mass. and BERLIN, Germany, January 22, 2019 / -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformati...

The first completed bio-banks will be used to develop more cost-effective, safe and efficacious cancer treatments Funding provided by European Horizon 2020 Resea...

CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies CAMBRIDGE and BOSTON, Mass. and BERLIN, Ge...

Appointment will drive scientific and technical innovation to streamline process workflows and advance ATMP service offering. Keele, UK, 15 January 2019: Cobra Biolog...

Updated 2019 guidelines for the treatment of Neisseria gonorrhoeae now recommend use of ciprofloxacin, provided susceptibility to the antimicrobial has been demons...